0001077183-21-000111.txt : 20210421
0001077183-21-000111.hdr.sgml : 20210421
20210421181959
ACCESSION NUMBER: 0001077183-21-000111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210419
FILED AS OF DATE: 20210421
DATE AS OF CHANGE: 20210421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mallon Mark
CENTRAL INDEX KEY: 0001763533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 21842692
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_161904358115470.xml
FORM 4
X0306
4
2021-04-19
0
0001077183
NEOGENOMICS INC
NEO
0001763533
Mallon Mark
12701 COMMONWEALTH DRIVE
SUITE 9
FORT MYERS
FL
33913
1
1
0
0
Chief Executive Officer
Common Stock
2021-04-19
4
A
0
55736
0
A
55736
D
Stock Option (Right to Buy)
49.34
2021-04-19
4
A
0
151016
0
A
2028-04-19
Common Stock
151016.0
151016
D
On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
/s/ Mark W. Mallon
2021-04-21